Carcinogenesis Advance Access published online on June 29, 2005
Carcinogenesis, doi:10.1093/carcin/bgi167
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
1 Department of Immunology, School of Medicine, Keimyung University, 194 DongSan-Dong Jung-Gu, Taegu 700-712, South Korea
* To whom correspondence should be addressed. Curcumin exhibits anti-inflammatory and anti-tumor activities. Although its functional mechanism has not been elucidated so far, numerous studies have shown that curcumin induces apoptosis in cancer cells. In the present study, we show that subtoxic concentrations of curcumin sensitize human renal cancer cells to the tumor necrosis factor-related apoptosis inducing ligand (TRAIL)-mediated apoptosis. This apoptosis induced by the combination of curcumin and TRAIL is not interrupted by Bcl-2 overexpression. We found that treatment with curcumin significantly induces DR5 expression both at its mRNA and protein levels, accompanying the generation of the reactive oxygen species (ROS). Not only the pretreatment with NAC but also the ectopic expression of peroxiredoxin II (Prx II), an anti-oxidative protein, dramatically inhibited the apoptosis induced by curcumin and TRAIL in combination, blocking of curcumin-mediated DR5 up-regulation. Taken together, the present study demonstrates that curcumin enhances TRAIL-induced apoptosis by ROS-mediated DR5 up-regulation. 3 Both these authors contributed equally to this work
Received April 7, 2005
Revised June 15, 2005
Accepted June 18, 2005
CANCER BIOLOGY
Curcumin sensitizes tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-induced apoptosis through reactive oxygen species-mediated up-regulation of death receptor 5 (DR5)
2 Institute for Medical Sciences, Ajou University School of Medicine, 5 Woncheon-Dong, Paldal-Gu, Suwon 442-749, South Korea
Taeg Kyu Kwon, E-mail: kwontk{at}dsmc.or.kr
![]()
Abstract ![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
S. Yodkeeree, B. Sung, P. Limtrakul, and B. B. Aggarwal Zerumbone Enhances TRAIL-Induced Apoptosis through the Induction of Death Receptors in Human Colon Cancer Cells: Evidence for an Essential Role of Reactive Oxygen Species Cancer Res., August 15, 2009; 69(16): 6581 - 6589. [Abstract] [Full Text] [PDF] |
||||
![]() |
I.-S. Song, S.-U. Kim, N.-S. Oh, J. Kim, D.-Y. Yu, S. M. Huang, J.-M. Kim, D.-S. Lee, and N.-S. Kim Peroxiredoxin I contributes to TRAIL resistance through suppression of redox-sensitive caspase activation in human hepatoma cells Carcinogenesis, July 1, 2009; 30(7): 1106 - 1114. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. H. Lim, J.-W. Park, K. S. Choi, Y. B. Park, and T. K. Kwon Rottlerin induces apoptosis via death receptor 5 (DR5) upregulation through CHOP-dependent and PKC {delta}-independent mechanism in human malignant tumor cells Carcinogenesis, May 1, 2009; 30(5): 729 - 736. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Shenoy, Y. Wu, and S. Pervaiz LY303511 Enhances TRAIL Sensitivity of SHEP-1 Neuroblastoma Cells via Hydrogen Peroxide-Mediated Mitogen-Activated Protein Kinase Activation and Up-regulation of Death Receptors Cancer Res., March 1, 2009; 69(5): 1941 - 1950. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. R. Hussain, M. Ahmed, N. A. Al-Jomah, A. S. Khan, P. Manogaran, M. Sultana, J. Abubaker, L. C. Platanias, K. S. Al-Kuraya, and S. Uddin Curcumin suppresses constitutive activation of nuclear factor-{kappa}B and requires functional Bax to induce apoptosis in Burkitt's lymphoma cell lines Mol. Cancer Ther., October 1, 2008; 7(10): 3318 - 3329. [Abstract] [Full Text] [PDF] |
||||
![]() |
R.-Y. Su, K.-H. Chi, D.-Y. Huang, M.-H. Tai, and W.-W. Lin 15-deoxy-{Delta}12,14-prostaglandin J2 up-regulates death receptor 5 gene expression in HCT116 cells: involvement of reactive oxygen species and C/EBP homologous transcription factor gene transcription Mol. Cancer Ther., October 1, 2008; 7(10): 3429 - 3440. [Abstract] [Full Text] [PDF] |
||||
![]() |
J.-J. Chen, C.-W. Chou, Y.-F. Chang, and C.-C. Chen Proteasome Inhibitors Enhance TRAIL-Induced Apoptosis through the Intronic Regulation of DR5: Involvement of NF-{kappa}B and Reactive Oxygen Species-Mediated p53 Activation J. Immunol., June 15, 2008; 180(12): 8030 - 8039. [Abstract] [Full Text] [PDF] |
||||
![]() |
R.-Y. Su, Y. Chao, T.-Y. Chen, D.-Y. Huang, and W.-W. Lin 5-Aminoimidazole-4-carboxamide riboside sensitizes TRAIL- and TNF{alpha}-induced cytotoxicity in colon cancer cells through AMP-activated protein kinase signaling Mol. Cancer Ther., May 1, 2007; 6(5): 1562 - 1571. [Abstract] [Full Text] [PDF] |
||||
![]() |
C.-Y. Jin, D.-O. Moon, J.-D. Lee, M.-S. Heo, Y. H. Choi, C.-M. Lee, Y.-M. Park, and G.-Y. Kim Sulforaphane sensitizes tumor necrosis factor-related apoptosis-inducing ligand-mediated apoptosis through downregulation of ERK and Akt in lung adenocarcinoma A549 cells Carcinogenesis, May 1, 2007; 28(5): 1058 - 1066. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. M. Jung, J.-W. Park, K. S. Choi, J.-W. Park, H. I. Lee, K.-S. Lee, and T. K. Kwon Curcumin sensitizes tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-mediated apoptosis through CHOP-independent DR5 upregulation Carcinogenesis, October 1, 2006; 27(10): 2008 - 2017. [Abstract] [Full Text] [PDF] |
||||



